Results 51 to 60 of about 1,041 (166)

Physiological importance of NGLY1, as revealed by rodent model analyses [PDF]

open access: yesThe Journal of Biochemistry, 2021
Abstract Cytosolic peptide:N-glycanase (NGLY1) is an enzyme that cleaves N-glycans from glycoproteins that has been retrotranslocated from the endoplasmic reticulum (ER) lumen into the cytosol. It is known that NGLY1 is involved in the degradation of cytosolic glycans (non-lysosomal glycan degradation) as well as ER-associated ...
Haruhiko, Fujihira   +2 more
openaire   +2 more sources

Tracing the NGLY1 footprints: insights from Drosophila [PDF]

open access: yesThe Journal of Biochemistry, 2021
Abstract Recessive mutations in human N-glycanase 1 (NGLY1) cause a multisystem disorder with various phenotypes including global developmental delay. One of the models utilized to understand the biology of NGLY1 and the pathophysiology of NGLY1 deficiency is Drosophila melanogaster, a well-established, genetically tractable organism ...
Ashutosh Pandey, Hamed Jafar-Nejad
openaire   +2 more sources

Loss of N-Glycanase 1 Alters Transcriptional and Translational Regulation in K562 Cell Lines

open access: yesG3: Genes, Genomes, Genetics, 2020
N-Glycanase 1 (NGLY1) deficiency is an ultra-rare, complex and devastating neuromuscular disease. Patients display multi-organ symptoms including developmental delays, movement disorders, seizures, constipation and lack of tear production.
William F. Mueller   +15 more
doaj   +1 more source

N-Glycanase 1 Transcriptionally Regulates Aquaporins Independent of Its Enzymatic Activity

open access: yesCell Reports, 2019
Summary: Patients with pathogenic mutations in NGLY1 cannot make tears and have global developmental delay and liver dysfunction. Traditionally, NGLY1 cleaves intact N-glycans from misfolded, retrotranslocated glycoproteins before proteasomal degradation.
Mitali A. Tambe   +2 more
doaj   +1 more source

Genetic disruption of mammalian endoplasmic reticulum‐associated protein degradation: Human phenotypes and animal and cellular disease models

open access: yesTraffic, Volume 24, Issue 8, Page 312-333, August 2023., 2023
Degradation of unassembled, misfolded, and other defective proteins is mediated by a major quality control mechanism, named the endoplasmic reticulum‐associated protein degradation (ERAD). Throughout this manuscript, we present the various genetically manipulated higher cellular and mammalian animal models that were depleted for specific ERAD ...
Sally Badawi   +3 more
wiley   +1 more source

NGLY1: insights from Caenorhabditis elegans [PDF]

open access: yesThe Journal of Biochemistry, 2021
Abstract Peptide:N-glycanase is an evolutionarily conserved deglycosylating enzyme that catalyses the removal of N-linked glycans from cytosolic glycoproteins. Recessive mutations that inactivate this enzyme cause NGLY1 deficiency, a multisystemic disorder with symptoms including developmental delay and defects in cognition and motor ...
openaire   +2 more sources

Increased recombinant adeno‐associated virus production by HEK293 cells using small molecule chemical additives

open access: yesBiotechnology Journal, Volume 18, Issue 3, March 2023., 2023
Graphical Abstract and Lay Summary Transient triple‐plasmid transfection‐based recombinant adeno‐associated virus (rAAV) production was carried out at microplate scale to allow for screening of multiple small molecule cell culture additives. Two chemicals (nocodazole and M344) were found to positively regulate rAAV genome titre when added to rAAV ...
Joseph M. Scarrott   +5 more
wiley   +1 more source

The STING pathway drives noninflammatory neurodegeneration in NGLY1 deficiency. [PDF]

open access: yesJ Exp Med
The STING pathway is increasingly recognized as a key regulator of neuroinflammation in neurodegenerative disease, but its role in noninflammatory conditions remains unclear. We generated a postnatal inducible whole-body Ngly1 knockout mouse (iNgly1−/−) to model NGLY1 deficiency, an early-onset neurodegenerative disorder.
Yang K   +15 more
europepmc   +3 more sources

Clinical and Molecular Features of Patients With Congenital Disorders of Glycosylation in Japan. [PDF]

open access: yesJIMD Rep
ABSTRACT Congenital disorders of glycosylation (CDG) are a heterogeneous group of diseases caused by defects in various steps of the glycosylation pathway. There are over 200 known human glycosylation‐related disorders. Many of these defects lead to multisystemic manifestations, commonly involving the central nervous system, with symptoms ranging from ...
Okamoto N, Kadoya M, Wada Y.
europepmc   +2 more sources

Off-target inhibition of NGLY1 by the polycaspase inhibitor Z-VAD-fmk induces cellular autophagy [PDF]

open access: yes, 2022
The polycaspase inhibitor Z-VAD-fmk acts as an inhibitor of peptide: N-glycanase (NGLY1), an endoglycosidase which cleaves N-linked glycans from glycoproteins exported from the endoplasmic reticulum (ER) during ER-associated degradation (ERAD).
Jeff E. Grotzke   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy